Rondecabtagene Autoleucel

· Lyell Immunopharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rondecabtagene Autoleucel, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma [Phase 1, Phase 2]